Thermo Long Term Investments vs Accounts Payable Analysis

TMO Stock

USD 521.66 0.00 0.00%

Thermo Fisher financial indicator trend analysis is much more than just breaking down Thermo Fisher Scientific prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Thermo Fisher Scientific is a good investment. Please check the relationship between Thermo Fisher Long Term Investments and its Accounts Payable accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Thermo Fisher Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Long Term Investments vs Accounts Payable

Long Term Investments vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Thermo Fisher Scientific Long Term Investments account and Accounts Payable. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Thermo Fisher's Long Term Investments and Accounts Payable is 0.8. Overlapping area represents the amount of variation of Long Term Investments that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Thermo Fisher Scientific, assuming nothing else is changed. The correlation between historical values of Thermo Fisher's Long Term Investments and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Investments of Thermo Fisher Scientific are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Long Term Investments i.e., Thermo Fisher's Long Term Investments and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.8

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Long Term Investments

Long Term Investments is an item on the asset side of Thermo Fisher balance sheet that represents investments Thermo Fisher Scientific intends to hold for over a year. Thermo Fisher Scientific long term investments may include different instruments such as stocks, bonds, real estate and cash.

Accounts Payable

An accounting item on the balance sheet that represents Thermo Fisher obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Thermo Fisher Scientific are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most indicators from Thermo Fisher's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Thermo Fisher Scientific current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Thermo Fisher Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

At this time, Thermo Fisher's Selling General Administrative is very stable compared to the past year. As of the 28th of November 2024, Tax Provision is likely to grow to about 469.3 M, while Discontinued Operations is likely to drop (3.6 M).

	2021	2022	2023	2024 (projected)
Total Revenue	39.2B	44.9B	42.9B	45.0B
Depreciation And Amortization	2.6B	3.4B	3.4B	3.6B

Total Revenue Depreciation And Amortization

Thermo Fisher fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Property Plant And Equipment Gross	Current Deferred Revenue	Good Will
Total Assets		0.99	0.9	0.97	0.99	0.98	0.95	0.97	0.75	0.99	0.43	0.75	0.99	0.38	0.98	0.99	0.98	-0.22	1.0	0.95	0.7	0.88	0.98	0.94	0.96	0.99
Short Long Term Debt Total	0.99		0.9	0.97	0.98	0.97	0.96	0.96	0.72	0.99	0.41	0.72	0.98	0.34	0.98	0.98	0.97	-0.23	1.0	0.93	0.71	0.88	0.96	0.94	0.96	0.99
Other Current Liab	0.9	0.9		0.91	0.88	0.91	0.9	0.88	0.56	0.91	0.43	0.56	0.9	0.28	0.87	0.91	0.89	-0.21	0.91	0.82	0.44	0.83	0.9	0.86	0.88	0.91
Total Current Liabilities	0.97	0.97	0.91		0.96	0.99	0.9	0.97	0.8	0.95	0.38	0.8	0.98	0.28	0.94	0.98	0.93	-0.3	0.98	0.96	0.77	0.8	0.98	0.95	0.97	0.96
Total Stockholder Equity	0.99	0.98	0.88	0.96		0.96	0.91	0.98	0.77	0.98	0.43	0.77	0.98	0.41	0.97	0.99	0.97	-0.21	0.98	0.95	0.69	0.86	0.97	0.93	0.94	0.99
Property Plant And Equipment Net	0.98	0.97	0.91	0.99	0.96		0.9	0.97	0.78	0.95	0.47	0.78	0.99	0.26	0.94	0.99	0.94	-0.35	0.98	0.96	0.7	0.78	1.0	0.96	0.98	0.96
Net Debt	0.95	0.96	0.9	0.9	0.91	0.9		0.89	0.51	0.97	0.35	0.51	0.91	0.37	0.94	0.92	0.95	-0.15	0.96	0.8	0.56	0.93	0.9	0.88	0.9	0.97
Retained Earnings	0.97	0.96	0.88	0.97	0.98	0.97	0.89		0.8	0.96	0.46	0.8	0.99	0.22	0.97	0.97	0.94	-0.41	0.96	0.97	0.69	0.76	0.97	0.98	0.98	0.97
Cash	0.75	0.72	0.56	0.8	0.77	0.78	0.51	0.8		0.67	0.39	1.0	0.79	0.14	0.71	0.77	0.67	-0.37	0.72	0.91	0.82	0.42	0.78	0.75	0.75	0.69
Non Current Assets Total	0.99	0.99	0.91	0.95	0.98	0.95	0.97	0.96	0.67		0.41	0.67	0.97	0.41	0.98	0.97	0.98	-0.18	0.99	0.9	0.65	0.91	0.95	0.93	0.94	1.0
Non Currrent Assets Other	0.43	0.41	0.43	0.38	0.43	0.47	0.35	0.46	0.39	0.41		0.39	0.49	-0.06	0.46	0.43	0.36	-0.35	0.42	0.46	0.04	0.26	0.45	0.44	0.5	0.42
Cash And Short Term Investments	0.75	0.72	0.56	0.8	0.77	0.78	0.51	0.8	1.0	0.67	0.39		0.79	0.14	0.71	0.77	0.67	-0.37	0.72	0.91	0.82	0.42	0.78	0.75	0.75	0.69
Net Receivables	0.99	0.98	0.9	0.98	0.98	0.99	0.91	0.99	0.79	0.97	0.49	0.79		0.26	0.97	0.99	0.95	-0.36	0.98	0.97	0.69	0.79	0.99	0.97	0.98	0.98
Common Stock Shares Outstanding	0.38	0.34	0.28	0.28	0.41	0.26	0.37	0.22	0.14	0.41	-0.06	0.14	0.26		0.28	0.37	0.44	0.71	0.35	0.26	0.25	0.63	0.3	0.11	0.14	0.36
Non Current Liabilities Total	0.98	0.98	0.87	0.94	0.97	0.94	0.94	0.97	0.71	0.98	0.46	0.71	0.97	0.28		0.95	0.97	-0.32	0.97	0.92	0.66	0.83	0.94	0.96	0.96	0.99
Inventory	0.99	0.98	0.91	0.98	0.99	0.99	0.92	0.97	0.77	0.97	0.43	0.77	0.99	0.37	0.95		0.96	-0.24	0.99	0.96	0.69	0.85	0.99	0.93	0.95	0.98
Other Current Assets	0.98	0.97	0.89	0.93	0.97	0.94	0.95	0.94	0.67	0.98	0.36	0.67	0.95	0.44	0.97	0.96		-0.15	0.97	0.9	0.64	0.9	0.94	0.91	0.92	0.98
Other Stockholder Equity	-0.22	-0.23	-0.21	-0.3	-0.21	-0.35	-0.15	-0.41	-0.37	-0.18	-0.35	-0.37	-0.36	0.71	-0.32	-0.24	-0.15		-0.22	-0.35	-0.2	0.2	-0.32	-0.51	-0.46	-0.23
Total Liab	1.0	1.0	0.91	0.98	0.98	0.98	0.96	0.96	0.72	0.99	0.42	0.72	0.98	0.35	0.97	0.99	0.97	-0.22		0.93	0.7	0.88	0.97	0.94	0.96	0.99
Total Current Assets	0.95	0.93	0.82	0.96	0.95	0.96	0.8	0.97	0.91	0.9	0.46	0.91	0.97	0.26	0.92	0.96	0.9	-0.35	0.93		0.78	0.7	0.96	0.93	0.94	0.92
Short Term Debt	0.7	0.71	0.44	0.77	0.69	0.7	0.56	0.69	0.82	0.65	0.04	0.82	0.69	0.25	0.66	0.69	0.64	-0.2	0.7	0.78		0.49	0.69	0.7	0.68	0.66
Intangible Assets	0.88	0.88	0.83	0.8	0.86	0.78	0.93	0.76	0.42	0.91	0.26	0.42	0.79	0.63	0.83	0.85	0.9	0.2	0.88	0.7	0.49		0.8	0.7	0.73	0.89
Accounts Payable	0.98	0.96	0.9	0.98	0.97	1.0	0.9	0.97	0.78	0.95	0.45	0.78	0.99	0.3	0.94	0.99	0.94	-0.32	0.97	0.96	0.69	0.8		0.94	0.96	0.96
Property Plant And Equipment Gross	0.94	0.94	0.86	0.95	0.93	0.96	0.88	0.98	0.75	0.93	0.44	0.75	0.97	0.11	0.96	0.93	0.91	-0.51	0.94	0.93	0.7	0.7	0.94		0.99	0.94
Current Deferred Revenue	0.96	0.96	0.88	0.97	0.94	0.98	0.9	0.98	0.75	0.94	0.5	0.75	0.98	0.14	0.96	0.95	0.92	-0.46	0.96	0.94	0.68	0.73	0.96	0.99		0.96
Good Will	0.99	0.99	0.91	0.96	0.99	0.96	0.97	0.97	0.69	1.0	0.42	0.69	0.98	0.36	0.99	0.98	0.98	-0.23	0.99	0.92	0.66	0.89	0.96	0.94	0.96

Click cells to compare fundamentals

Thermo Fisher Account Relationship Matchups

Thermo Fisher fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	58.4B	69.1B	95.1B	97.2B	98.7B	103.7B
Short Long Term Debt Total	17.8B	21.7B	34.9B	34.5B	34.9B	36.7B
Other Current Liab	2.7B	3.9B	5.4B	5.4B	4.8B	5.1B
Total Current Liabilities	6.2B	10.3B	13.4B	17.0B	14.0B	14.7B
Total Stockholder Equity	29.7B	34.5B	40.8B	44.0B	46.7B	49.1B
Property Plant And Equipment Net	5.4B	6.7B	9.9B	10.9B	9.4B	9.9B
Net Debt	15.4B	11.4B	30.4B	26.0B	26.8B	28.2B
Retained Earnings	22.1B	28.1B	35.4B	41.9B	47.4B	49.7B
Cash	2.4B	10.3B	4.5B	8.5B	8.1B	8.5B
Non Current Assets Total	45.2B	45.5B	72.0B	69.7B	74.1B	77.8B
Non Currrent Assets Other	1.9B	2.5B	4.4B	(2.8B)	2.1B	2.2B
Cash And Short Term Investments	2.4B	10.3B	4.5B	8.5B	8.1B	8.5B
Net Receivables	5.0B	6.5B	8.9B	9.4B	9.7B	10.1B
Common Stock Shares Outstanding	403M	399M	397M	394M	388M	272.7M
Liabilities And Stockholders Equity	58.4B	69.1B	95.1B	97.2B	98.7B	103.7B
Non Current Liabilities Total	17.1B	19.1B	32.1B	28.8B	37.9B	39.8B
Inventory	3.4B	4.0B	5.1B	5.6B	5.1B	5.3B
Other Current Assets	1.2B	1.1B	1.6B	1.6B	1.8B	1.8B
Other Stockholder Equity	7.1B	8.8B	7.3B	4.7B	2.2B	2.0B
Total Liab	28.7B	34.5B	54.1B	53.0B	51.9B	54.5B
Total Current Assets	11.9B	22.0B	20.1B	25.2B	24.6B	25.8B
Short Term Debt	676M	2.8B	2.5B	5.6B	3.6B	3.8B
Intangible Assets	14.0B	12.7B	20.1B	17.5B	16.7B	17.5B
Accounts Payable	1.9B	2.2B	2.9B	3.4B	2.9B	3.0B
Property Plant And Equipment Gross	4.7B	5.9B	12.6B	14.3B	15.5B	16.3B
Accumulated Other Comprehensive Income	(2.7B)	(2.8B)	(2.3B)	(3.1B)	(3.2B)	(3.1B)
Current Deferred Revenue	916M	1.3B	2.7B	2.6B	2.7B	2.8B
Good Will	25.7B	26.0B	41.9B	41.2B	44.0B	46.2B
Common Stock Total Equity	434M	437M	439M	441M	507.2M	352.8M
Short Term Investments	10M	3M	37M	28M	1.8M	1.7M
Common Stock	434M	437M	439M	441M	442M	357.4M
Other Liab	4.8B	5.1B	8.1B	5.7B	6.5B	6.9B
Other Assets	1.2B	1.6B	3.0B	2.2B	2.6B	2.7B
Long Term Debt	17.1B	19.1B	32.3B	28.9B	31.3B	32.9B
Treasury Stock	(3.7B)	(5.2B)	(6.8B)	(8.9B)	(8.0B)	(7.6B)
Property Plant Equipment	4.7B	5.9B	8.3B	9.3B	10.7B	11.2B
Net Tangible Assets	(10.1B)	(4.2B)	(21.2B)	(14.5B)	(13.1B)	(13.7B)
Retained Earnings Total Equity	22.1B	28.1B	35.4B	41.9B	48.2B	50.6B

Pair Trading with Thermo Fisher

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Thermo Fisher position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Thermo Fisher will appreciate offsetting losses from the drop in the long position's value.

Moving together with Thermo Stock

0.76	A	Agilent Technologies	Pair Corr
0.77	VALN	Valneva SE ADR	Pair Corr

Moving against Thermo Stock

0.87	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.84	ESPR	Esperion Therapeutics	Pair Corr
0.77	DRUG	Bright Minds Biosciences	Pair Corr
0.74	GILD	Gilead Sciences	Pair Corr
0.49	NBY	NovaBay Pharmaceuticals	Pair Corr

The ability to find closely correlated positions to Thermo Fisher could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Thermo Fisher when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Thermo Fisher - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Thermo Fisher Scientific to buy it.

The correlation of Thermo Fisher is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Thermo Fisher moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Thermo Fisher Scientific moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Thermo Fisher can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Thermo Fisher Scientific offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Thermo Fisher's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Thermo Fisher Scientific Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Thermo Fisher Scientific Stock:

How To Invest In Thermo

Details

Is Thermo Stock a good investment?

Details

What is Thermo Fisher's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Thermo Fisher Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Thermo Fisher. If investors know Thermo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Thermo Fisher listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.04)

Dividend Share

1.52

Earnings Share

15.95

Revenue Per Share

110.627

Quarterly Revenue Growth

0.002

The market value of Thermo Fisher Scientific is measured differently than its book value, which is the value of Thermo that is recorded on the company's balance sheet. Investors also form their own opinion of Thermo Fisher's value that differs from its market value or its book value, called intrinsic value, which is Thermo Fisher's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Thermo Fisher's market value can be influenced by many factors that don't directly affect Thermo Fisher's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Thermo Fisher's value and its price as these two are different measures arrived at by different means. Investors typically determine if Thermo Fisher is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Thermo Fisher's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Thermo Long Term Investments vs Accounts Payable Analysis

Long Term Investments vs Accounts Payable

Long Term Investments vs Accounts Payable Correlation Analysis

Correlation Coefficient

Long Term Investments

Accounts Payable

Thermo Fisher fundamental ratios Correlations

Thermo Fisher Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Thermo Fisher fundamental ratios Accounts

Pair Trading with Thermo Fisher

Moving together with Thermo Stock

Moving against Thermo Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Assets
Total Liab	+ 1.0	Short Long Term Debt Total
Accounts Payable	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Good Will	+ 1.0	Non Current Assets Total
Short Long Term Debt Total	+ 0.99	Total Assets

Property Plant And Equipment Gross	- 0.51	Other Stockholder Equity
Current Deferred Revenue	- 0.46	Other Stockholder Equity
Other Stockholder Equity	- 0.41	Retained Earnings
Other Stockholder Equity	- 0.37	Cash And Short Term Investments
Other Stockholder Equity	- 0.37	Cash
Other Stockholder Equity	- 0.36	Net Receivables